APA (7th ed.) Citation

El-Gendy, N., EL-Raey, F., Nassib, S., & Elsadany, N. (2020). Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis. Al-Azhar University, Faculty of Medicine (Damietta).

Chicago Style (17th ed.) Citation

El-Gendy, Naglaa, Fathiya EL-Raey, Sherif Nassib, and Noha Elsadany. Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis. Al-Azhar University, Faculty of Medicine (Damietta), 2020.

MLA (8th ed.) Citation

El-Gendy, Naglaa, et al. Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis. Al-Azhar University, Faculty of Medicine (Damietta), 2020.